| Line item | 2026-03-31 FY | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2022-03-31 FY | 2021-03-31 FY |
|---|---|---|---|---|---|---|
| Revenue | – | – | – | – | $100.00M | $196.00K |
| Cost of Revenue | – | – | – | – | $0.00 | $76.00K |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – | – |
| R&D | $2.40M | $9.51M | $4.68M | $9.97M | $5.56M | $4.17M |
| SG&A | $8.67M | $7.17M | $6.43M | $7.61M | $9.26M | $5.52M |
| Operating Income | -$11.08M | -$16.68M | -$12.85M | -$52.16M | -$15.59M | -$16.42M |
| Interest Expense | – | – | – | – | – | – |
| Tax Expense | -$1.70M | -$3.20M | -$1.83M | -$9.54M | -$648.00K | $0.00 |
| Net Income | -$7.79M | -$9.57M | -$12.85M | -$42.43M | -$9.82M | -$19.68M |
| EPS (basic) | -0.4700 | -0.7900 | -1.3500 | -0.9500 | -0.2700 | – |
| EPS (diluted) | -0.4700 | -0.7900 | -1.3500 | -0.9500 | -0.2700 | – |
| Shares (diluted) | $16.51M | $12.09M | $9.53M | $44.61M | $36.84M | – |